Toxicity and dose intensity of FOLFOX in patients with increased body mass index


Autoria(s): Suibhne,SN; King,F; Treacy,V; Kennedy,J; Collins,I; Weidmann,AE
Data(s)

01/01/2014

Resumo

This study was conducted at St James‘s Hospital, Dublin, Ireland, in 2010. It evaluated the dose intensity and toxicities experienced by patients of normal and increased body mass index treated with FOLFOX chemotherapy, and demonstrated that overweight patients may tolerate doses based on actual body weight.

Identificador

http://hdl.handle.net/10536/DRO/DU:30072795

Idioma(s)

eng

Publicador

Pharma Publishing and Media Europe

Relação

http://dro.deakin.edu.au/eserv/DU:30072795/t030520-collins-toxicityand-2014.pdf

Direitos

2014,Pharma Publishing and Media Europe

Tipo

Journal Article